Multi‐omics profiling identifies TNFRSF18 as a novel marker of exhausted CD8⁺ T cells and reveals tumour‐immune dynamics in colorectal cancer
Clinical and Translational Medicine · 2025-08 · 15 (8)
DOI: 10.1002/ctm2.70425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 06.08.2025. Verfasst von Tengfei Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Higher Education Institution-Key Program, Soochow University Research Development Funds, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) ranks among the most prevalent malignant tumours of the digestive system globally and is associated with unfavourable survival outcomes. The exhaustion of CD8⁺ T cells serves a crucial role in facilitating tumour immune escape. Yet, the dynamic evolution of CD8⁺ T cell exhaustion and its impact on clinical prognosis across TNM (tumour‐node‐metastasis) stages in CRC remains incompletely characterized.
Methods
Tumour and adjacent tissues (20 samples total) from 6 CRC patients spanning diverse TNM stages were analyzed using integrated single‐cell transcriptomic profiling (scRNA‐seq), single‐cell T cell receptor/B cell receptor sequencing (scVDJ‐seq), and spatial transcriptomics. T cell exhaustion markers, immune clonality, gene expression profiles, and the spatial distribution of both tumour cells and immune cells were systematically profiled. Functional enrichment and intercellular communication analyses were conducted. Key findings were validated using immunofluorescence and public datasets.
Results
Our results illustrate how advancing TNM stages in CRC shape CD8⁺ T cell exhaustion through divergent TNFRSF18/CXCL13 dynamics and ribosomal stemness. TNFRSF18 expression was notably higher in T cells infiltrating tumour tissues relative to their counterparts in adjacent non‐tumorous areas, with high‐expressing CD8⁺ T cells exhibiting marked exhaustion features. During CRC progression, TNM‐stage‐driven remodelling of the tumour microenvironment (TME) induced progressive CD8⁺ T cell exhaustion marked by declining TNFRSF18 and rising CXCL13 expression in tumour‐infiltrating T cells elevation of both markers in the tumour compared with adjacent tissues. Moreover, we show that tumour cells displayed elevated expression of stemness‐associated ribosomal genes ( RPS7 , RPL8 , RPL30 ), peaking at stage T4, which correlated with poor prognosis and immune escape.
Conclusions
This integrative multi‐omics study uncovers CD8⁺ T cell exhaustion dynamics and ribosomal stemness‐mediated immune evasion across CRC progression. CXCL13 , TNFRSF18 , and ribosomal proteins ( RPS7 / RPL8 / RPL30 ) are identified as novel biomarkers with direct prognostic value and therapeutic relevance, providing therapeutic targets for precision immunotherapy in CRC. Key points Multi‐omics analysis reveals dynamic CD8 + T cell exhaustion patterns across CRC samples with different TNM stages. TNFRSF18 is highly expressed in exhausted tumour‐infiltrating CD8 + T cells and declines with disease progression. Ribosomal stemness in tumour cells promotes immune evasion by impairing TNF‐mediated CD8 + T cell function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.
- Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Tulane University School of Medicine, New Orleans, Louisiana, USA.
- Cancer Institute, Suzhou Medical College, Soochow University, Suzhou, China.
- National Center of Technology Innovation for Biopharmaceuticals, Suzhou, China.
ORCID-Profile: Tengfei Jia
Förderung
- Natural Science Foundation of Jiangsu Higher Education Institution-Key Program
- Soochow University Research Development Funds
- National Natural Science Foundation of China
- Suzhou Technology Bureau
- Provincial-level Talent Program for National Center of Technology Innovation for Biopharmaceuticals
- Science and Technology Foundation of Jiangsu Province
Zitieren
APA
Jia, T., Guo, Y., Cheng, X. M., Zhou, Z., Xu, X., Liu, H., & Yang, X. (2025). Multi‐omics profiling identifies TNFRSF18 as a novel marker of exhausted CD8⁺ T cells and reveals tumour‐immune dynamics in colorectal cancer. Clinical and Translational Medicine, 15(8). https://doi.org/10.1002/ctm2.70425
Vancouver
Jia T, Guo Y, Cheng XM, Zhou Z, Xu X, Liu H, et al. Multi‐omics profiling identifies TNFRSF18 as a novel marker of exhausted CD8⁺ T cells and reveals tumour‐immune dynamics in colorectal cancer. Clinical and Translational Medicine. 2025;15(8). doi:10.1002/ctm2.70425
BibTeX
@article{Jia2025,
author = {Jia, Tengfei and Guo, Yingxi and Cheng, Xin Meng and Zhou, Zeyang and Xu, Xiaojiang and Liu, Hebin and Yang, Xiaodong},
title = {Multi‐omics profiling identifies TNFRSF18 as a novel marker of exhausted CD8⁺ T cells and reveals tumour‐immune dynamics in colorectal cancer},
journal = {Clinical and Translational Medicine},
year = {2025},
volume = {15},
number = {8},
doi = {10.1002/ctm2.70425}
}
EUVIMED